STAT3h
Turbulence at the FDA & bluebird Bio’s sale
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
FierceBiotech5h
Chutes & Ladders—Private equity firms take over bluebird's nest
Gene therapy maker bluebird bio’s 15-year flight has landed in the nest of private equity firms Carlyle and SK Capital in a ...
STAT21h
Turbulence at the FDA, Bluebird Bio’s sale and young biotech VCs
What’s it like reporting on the FDA during the early and turbulent weeks of the Trump administration? Why did Bluebird Bio ...